Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator

scientific article published in September 2002

Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1067/MHJ.2002.125501
P698PubMed publication ID12228780

P50authorMark A. HlatkyQ56166694
Kathryn M. McDonaldQ59748119
Douglas K OwensQ98149051
Paul A HeidenreichQ37840942
P2093author name stringGillian D Sanders
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectdefibrillatorQ1450682
P304page(s)440-448
P577publication date2002-09-01
P1433published inAmerican Heart JournalQ2227156
P1476titleEffect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator
P478volume144

Reverse relations

cites work (P2860)
Q45978202Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals.
Q36711669Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation
Q36710908Competing risk and heterogeneity of treatment effect in clinical trials
Q37844148Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies
Q37873923Decision-analytic models to simulate health outcomes and costs in heart failure: a systematic review
Q44604863Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth
Q43776255Detectable troponin levels predict poor prognosis in patients with left ventricular dysfunction undergoing internal defibrillator implantation
Q46986132Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
Q82208052Effect of Renal Function on Survival After Implantable Cardioverter Defibrillator Placement
Q37411838Expenditure and value for money: the challenge of implantable cardioverter defibrillators
Q39110914Improving the Methods for the Economic Evaluation of Medical Devices
Q36721259Long-Term Prognosis in Recipients of Implantable Cardioverter-Defibrillators for Secondary Preventions in Taiwan - A Multicenter Registry Study
Q36014154Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction
Q50918488Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.
Q45170638Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government
Q38163484The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluations

Search more.